179 related articles for article (PubMed ID: 15921805)
1. Effects of nebivolol on left ventricular function in elderly patients with chronic heart failure: results of the ENECA study.
Edes I; Gasior Z; Wita K
Eur J Heart Fail; 2005 Jun; 7(4):631-9. PubMed ID: 15921805
[TBL] [Abstract][Full Text] [Related]
2. [Influence of the beta-blocker nebivolol on left ventricular function in patients with chronic heart failure].
Wolf SC; Buck-Müller N; Görner S; Risler T; Brehm BR
Med Klin (Munich); 2003 Jan; 98(1):1-6. PubMed ID: 12540987
[TBL] [Abstract][Full Text] [Related]
3. Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure).
van Veldhuisen DJ; Cohen-Solal A; Böhm M; Anker SD; Babalis D; Roughton M; Coats AJ; Poole-Wilson PA; Flather MD;
J Am Coll Cardiol; 2009 Jun; 53(23):2150-8. PubMed ID: 19497441
[TBL] [Abstract][Full Text] [Related]
4. Effects of the long-term administration of nebivolol on the clinical symptoms, exercise capacity, and left ventricular function of patients with diastolic dysfunction: results of the ELANDD study.
Conraads VM; Metra M; Kamp O; De Keulenaer GW; Pieske B; Zamorano J; Vardas PE; Böhm M; Dei Cas L
Eur J Heart Fail; 2012 Feb; 14(2):219-25. PubMed ID: 22147202
[TBL] [Abstract][Full Text] [Related]
5. Nebivolol for heart failure in the elderly.
Tavazzi L
Expert Rev Cardiovasc Ther; 2007 May; 5(3):423-33. PubMed ID: 17489667
[TBL] [Abstract][Full Text] [Related]
6. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS).
Flather MD; Shibata MC; Coats AJ; Van Veldhuisen DJ; Parkhomenko A; Borbola J; Cohen-Solal A; Dumitrascu D; Ferrari R; Lechat P; Soler-Soler J; Tavazzi L; Spinarova L; Toman J; Böhm M; Anker SD; Thompson SG; Poole-Wilson PA;
Eur Heart J; 2005 Feb; 26(3):215-25. PubMed ID: 15642700
[TBL] [Abstract][Full Text] [Related]
7. [Optimization of use of beta-adrenoblockers in the treatment of chronic heart failure in the outpatient setting].
Zhubrina ES; Ovchinnikov AG; Seredenina EM; Patrusheva IF; Blankova ZN; Kuz'mina AE; Kheĭmets GI; Ageev FT
Ter Arkh; 2009; 81(11):35-40. PubMed ID: 20141011
[TBL] [Abstract][Full Text] [Related]
8. Effect of nebivolol on left ventricular function in patients with chronic heart failure: a pilot study.
Brehm BR; Wolf SC; Görner S; Buck-Müller N; Risler T
Eur J Heart Fail; 2002 Dec; 4(6):757-63. PubMed ID: 12453547
[TBL] [Abstract][Full Text] [Related]
9. ENOS is not activated by nebivolol in human failing myocardium.
Brixius K; Song Q; Malick A; Boelck B; Addicks K; Bloch W; Mehlhorn U; Schwinger RH
Life Sci; 2006 Aug; 79(13):1234-41. PubMed ID: 16716362
[TBL] [Abstract][Full Text] [Related]
10. Beta-blocker improves survival, left ventricular function, and myocardial remodeling in hypertensive rats with diastolic heart failure.
Kobayashi M; Machida N; Mitsuishi M; Yamane Y
Am J Hypertens; 2004 Dec; 17(12 Pt 1):1112-9. PubMed ID: 15607617
[TBL] [Abstract][Full Text] [Related]
11. [Elderly heart failure patients and the role of beta-blocker therapy].
Middeljans-Tijssen CW; Jansen RW
Tijdschr Gerontol Geriatr; 2006 Apr; 37(2):67-77. PubMed ID: 16704019
[TBL] [Abstract][Full Text] [Related]
12. Comparison of effects on systolic and diastolic left ventricular function of nebivolol versus atenolol in patients with uncomplicated essential hypertension.
Kamp O; Sieswerda GT; Visser CA
Am J Cardiol; 2003 Aug; 92(3):344-8. PubMed ID: 12888152
[TBL] [Abstract][Full Text] [Related]
13. Hemodynamic effects of nebivolol at rest and on exertion in patients with heart failure.
Brune S; Schmidt T; Tebbe U; Kreuzer H
Angiology; 1990 Sep; 41(9 Pt 1):696-701. PubMed ID: 1977335
[TBL] [Abstract][Full Text] [Related]
14. The importance of heart rate recovery in patients with heart failure or left ventricular systolic dysfunction.
Lipinski MJ; Vetrovec GW; Gorelik D; Froelicher VF
J Card Fail; 2005 Oct; 11(8):624-30. PubMed ID: 16230267
[TBL] [Abstract][Full Text] [Related]
15. Clinical and economic aspects of the use of nebivolol in the treatment of elderly patients with heart failure.
Del Sindaco D; Tinti MD; Monzo L; Pulignano G
Clin Interv Aging; 2010 Dec; 5():381-93. PubMed ID: 21152240
[TBL] [Abstract][Full Text] [Related]
16. [Initial data on nebivolol in heart failure. Beta blockers strengthen older hearts, too].
MMW Fortschr Med; 2003 May; 145(22):55. PubMed ID: 12866284
[No Abstract] [Full Text] [Related]
17. Nebivolol: a third-generation beta-adrenergic blocker.
Veverka A; Nuzum DS; Jolly JL
Ann Pharmacother; 2006; 40(7-8):1353-60. PubMed ID: 16822893
[TBL] [Abstract][Full Text] [Related]
18. Comparative cardiac haemodynamics of bisoprolol, celiprolol, carvedilol and nebivolol in normal volunteers.
De Cree J; Van Nueten L; Geukens H; Verhaegen H
Int J Clin Pharmacol Res; 1992; 12(4):159-63. PubMed ID: 1363660
[TBL] [Abstract][Full Text] [Related]
19. [Role of the L-arginine/nitric oxide system in the action of nebivolol].
Brodde OE; Philipp T
Dtsch Med Wochenschr; 2006 Nov; 131(45):2545-50. PubMed ID: 17091442
[TBL] [Abstract][Full Text] [Related]
20. Influence of diabetes mellitus and hyperglycemia on prognosis in patients > or =70 years old with heart failure and effects of nebivolol (data from the Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors with heart failure [SENIORS]).
de Boer RA; Doehner W; van der Horst IC; Anker SD; Babalis D; Roughton M; Coats AJ; Flather MD; van Veldhuisen DJ;
Am J Cardiol; 2010 Jul; 106(1):78-86.e1. PubMed ID: 20609652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
